Virtu Financial LLC Vascular Biogenics Ltd. Transaction History

Virtu Financial LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.15 - $0.27 $6,370 - $11,466	42,468 Added 113.48%	79,892 $18,000
Q1 2023 May 01, 2023	SELL	$0.13 - $0.19 $1,883 - $2,753	-14,491 Reduced 27.91%	37,424 $6,000
Q4 2022 Feb 15, 2023	SELL	$0.11 - $0.16 $4,418 - $6,427	-40,170 Reduced 43.62%	51,915 $6,000
Q3 2022 Nov 07, 2022	BUY	$0.15 - $2.1 $11,410 - $159,751	76,072 Added 475.06%	92,085 $14,000
Q2 2022 Aug 09, 2022	BUY	$1.22 - $1.95 $19,535 - $31,225	16,013 New	16,013 $26,000
Q1 2022 May 17, 2022	SELL	$1.15 - $1.97 $14,192 - $24,311	-12,341 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$1.92 - $2.53 $5,677 - $7,481	-2,957 Reduced 19.33%	12,341 $24,000
Q3 2021 Nov 12, 2021	SELL	$1.94 - $2.55 $47,180 - $62,015	-24,320 Reduced 61.39%	15,298 $31,000
Q2 2021 Sep 17, 2021	BUY	$1.69 - $2.67 $66,954 - $105,780	39,618 New	39,618 $95,000
Q4 2020 Feb 24, 2021	SELL	$1.07 - $2.0 $59,027 - $110,332	-55,166 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$1.11 - $1.4 $39,700 - $50,072	35,766 Added 184.36%	55,166 $67,000
Q2 2020 Aug 07, 2020	BUY	$1.12 - $1.63 $21,728 - $31,621	19,400 New	19,400 $25,000
Q4 2018 Jan 16, 2019	SELL	$0.6 - $1.72 $7,393 - $21,195	-12,323 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$1.55 - $2.17 $21,813 - $30,538	-14,073 Reduced 53.31%	12,323 $20,000
Q2 2018 Jul 30, 2018	SELL	$2.05 - $3.0 $23,392 - $34,233	-11,411 Reduced 30.18%	26,396 $58,000
Q2 2018 Jul 30, 2018	SELL	$2.05 - $3.0 $62,350 - $91,245	-30,415 Reduced 44.58%	37,807 $83,000
Q1 2018 May 14, 2018	BUY	$2.27 - $8.5 $154,863 - $579,887	68,222 New	68,222 $157,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.